Targeting PGK1: A New Frontier in Breast Cancer Therapy Under Hypoxic Conditions

Overview

Journal Curr Issues Mol Biol

Publisher MDPI

Specialty Molecular Biology

Date 2024 Nov 26

PMID 39590319

Authors

Jiayong Cui

Shengjun Chai

Rui Liu

Guoshuang Shen

Affiliations

Soon will be listed here.

Abstract

Breast cancer represents one of the most prevalent malignant neoplasms affecting women, and its pathogenesis has garnered significant scholarly interest. Research indicates that the progression of breast cancer is intricately regulated by glucose metabolism. Under hypoxic conditions within the tumor microenvironment, breast cancer cells generate ATP and essential biosynthetic precursors for growth via the glycolytic pathway. Notably, phosphoglycerate kinase 1 (PGK1) is intimately associated with the regulation of hypoxia-inducible factors in breast cancer and plays a crucial role in modulating glycolytic processes. Further investigation into the role of PGK1 in breast cancer pathogenesis is anticipated to identify novel therapeutic targets and strategies. This review consolidates current research on the regulation of glucose metabolism and the function of PGK1 in breast cancer within hypoxic conditions. It aims to offer a significant theoretical foundation for elucidating the mechanisms underlying breast cancer progression and metastasis, thereby facilitating the development of innovative treatment approaches.

References

Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E . SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature. 2012; 487(7407):380-4. DOI: 10.1038/nature11207. View

Manjunath M, Ravindran F, Sharma S, Siddiqua H, Raghavan S, Choudhary B . Disarib, a Specific BCL2 Inhibitor, Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression in Xenografts by Altering Mitochondria-Associated Processes. Int J Mol Sci. 2024; 25(12). PMC: 11203414. DOI: 10.3390/ijms25126485. View

Hu T, He N, Yang Y, Yin C, Sang N, Yang Q . DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas. J Exp Clin Cancer Res. 2015; 34:22. PMC: 4379712. DOI: 10.1186/s13046-015-0135-8. View

Pralea I, Petrache A, Tigu A, Gulei D, Moldovan R, Ilies M . Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies. Pharmaceuticals (Basel). 2022; 15(7). PMC: 9315613. DOI: 10.3390/ph15070808. View

Lucchetti D, Ricciardi Tenore C, Colella F, Sgambato A . Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity. Cancers (Basel). 2020; 12(1). PMC: 7016590. DOI: 10.3390/cancers12010171. View

Mubtasim N, Moustaid-Moussa N, Gollahon L . The Complex Biology of the Obesity-Induced, Metastasis-Promoting Tumor Microenvironment in Breast Cancer. Int J Mol Sci. 2022; 23(5). PMC: 8910079. DOI: 10.3390/ijms23052480. View

Alves K, Costa C, Remedios C, Calcagno D, de Oliveira Lima M, Silva J . LDH-Indomethacin Nanoparticles Antitumoral Action: A Possible Coadjuvant Drug for Cancer Therapy. Molecules. 2024; 29(14). PMC: 11279815. DOI: 10.3390/molecules29143353. View

Li L, Liang Y, Kang L, Liu Y, Gao S, Chen S . Transcriptional Regulation of the Warburg Effect in Cancer by SIX1. Cancer Cell. 2018; 33(3):368-385.e7. DOI: 10.1016/j.ccell.2018.01.010. View

Ros S, Santos C, Moco S, Baenke F, Kelly G, Howell M . Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. Cancer Discov. 2012; 2(4):328-43. DOI: 10.1158/2159-8290.CD-11-0234. View

10.

Hong R, Xu B . Breast cancer: an up-to-date review and future perspectives. Cancer Commun (Lond). 2022; 42(10):913-936. PMC: 9558690. DOI: 10.1002/cac2.12358. View

11.

Costa B, Vale N . Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer. Int J Mol Sci. 2022; 23(6). PMC: 8951384. DOI: 10.3390/ijms23063181. View

12.

Yang J, Song C, Zhan X . The role of protein acetylation in carcinogenesis and targeted drug discovery. Front Endocrinol (Lausanne). 2022; 13:972312. PMC: 9510633. DOI: 10.3389/fendo.2022.972312. View

13.

Zhang D, Tai L, Wong L, Chiu L, Sethi S, Koay E . Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics. 2005; 4(11):1686-96. DOI: 10.1074/mcp.M400221-MCP200. View

14.

Dubsky P, Jackisch C, Im S, Hunt K, Li C, Unger S . BRCA genetic testing and counseling in breast cancer: how do we meet our patients' needs?. NPJ Breast Cancer. 2024; 10(1):77. PMC: 11377442. DOI: 10.1038/s41523-024-00686-8. View

15.

Xie S, Li X, Zhao J, Zhang F, Shu Z, Cheng H . The effect and mechanism of hexokinase-2 on cisplatin resistance in lung cancer cells A549. Environ Toxicol. 2024; 39(5):2667-2680. DOI: 10.1002/tox.24140. View

16.

Vanhove K, Derveaux E, Graulus G, Mesotten L, Thomeer M, Noben J . Glutamine Addiction and Therapeutic Strategies in Lung Cancer. Int J Mol Sci. 2019; 20(2). PMC: 6359540. DOI: 10.3390/ijms20020252. View

17.

Nikoo M, Rudiansyah M, Olegovich Bokov D, Jainakbaev N, Suksatan W, Javed Ansari M . Potential of chimeric antigen receptor (CAR)-redirected immune cells in breast cancer therapies: Recent advances. J Cell Mol Med. 2022; 26(15):4137-4156. PMC: 9344815. DOI: 10.1111/jcmm.17465. View

18.

Francavilla C, OBrien C . Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer. Open Biol. 2022; 12(2):210373. PMC: 8864352. DOI: 10.1098/rsob.210373. View

19.

Gottfried E, Kunz-Schughart L, Ebner S, Mueller-Klieser W, Hoves S, Andreesen R . Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood. 2005; 107(5):2013-21. DOI: 10.1182/blood-2005-05-1795. View

20.

Li X, Jiang Y, Meisenhelder J, Yang W, Hawke D, Zheng Y . Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. Mol Cell. 2016; 61(5):705-719. PMC: 4888784. DOI: 10.1016/j.molcel.2016.02.009. View